🔥🐔 BizChicken 🐔🔥
Companies Similar to Madrigal Pharmaceuticals, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
AnaptysBio, Inc.
Imsidolimab, Rosnilimab, ANB032
Anaptys Bio, Inc. is a clinical stage biotechnology company focused on developing therapeutic product candidates for inflammation and immuno-oncology indications. Their products target dermatological inflammatory diseases and other human inflammatory conditions.
Symbol: ANAB
Recent Price: $13.22
Industry: Biotechnology
CEO: Mr. Daniel R. Faga
Sector: Healthcare
Employees: 117
Address: 10770 Wateridge Circle, San Diego, CA 92121-5801
Phone: 858 362 6295
Last updated: 2024-12-31
Hepion Pharmaceuticals, Inc.
Rencofilstat
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing drug therapies for chronic liver diseases, particularly through the development of Rencofilstat, a cyclophilin inhibitor aimed at treating non-alcoholic steatohepatitis (NASH) and reducing liver fibrosis and tumors.
About | Leadership | About | About | About | News | Contact | Careers | About | About | About
Symbol: HEPA
Recent Price: $0.43
Industry: Biotechnology
CEO: Mr. John Patrick Brancaccio CPA
Sector: Healthcare
Employees: 22
Address: 399 Thornall Street, Edison, NJ 08837
Phone: 732 902 4000
Leadership
- John P. Brancaccio, Interim Chief Executive Officer, Interim Chief Financial Officer, and Chairman of the Board
Last updated: 2024-12-31
Regeneron Pharmaceuticals, Inc.
EYLEA, Dupixent, Libtayo, Praluent, REGEN-COV, Kevzara, Inmazeb
Regeneron Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes medicines for treating various diseases worldwide, including treatments like EYLEA, Dupixent, Libtayo, and more.
About | Leadership | About | History | About | About | Contact | Careers | Careers | Jobs | Jobs | Jobs | Careers | Culture | DEI | Careers | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Careers | Careers | Careers | Locations | Locations | Locations | Locations | Events | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Site Map | Careers | About | About | About | About | Jobs | About | Leadership | Careers | Careers | About | Jobs | Jobs | Careers
Symbol: REGN
Recent Price: $702.59
Industry: Biotechnology
CEO: Dr. Leonard S. Schleifer M.D., Ph.D.
Sector: Healthcare
Employees: 14165
Address: 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707
Phone: 914 847 7000
Leadership
- Leonard S. Schleifer, MD, PhD, Board co-Chair, President and Chief Executive Officer
- George D. Yancopoulos, MD, PhD, Board co-Chair, President and Chief Scientific Officer
- Zoran Berkovic, Senior Vice President, Financial Planning and Analysis
- Maya Bermingham, Senior Vice President, Public Policy and Government Affairs
- Leonard Brooks, Senior Vice President, Treasurer
- John Calabro, Senior Vice President, Internal Audit
- Christina Chan, Senior Vice President, Corporate Affairs
- Larry Coury, PhD, Senior Vice President, Associate General Counsel
- Ryan Crowe, Senior Vice President, Investor Relations & Strategic Analysis
- Matthew Everett, Senior Vice President, Global Procurement
- Chris Fenimore, Senior Vice President, Finance and Chief Financial Officer
- Rick Hall, Senior Vice President, Human Resources
- Justin Holko, Senior Vice President, Global Oncology/Hematology Commercial Business Unit
- Nouhad Husseini, Senior Vice President, Business Development
- Joseph J. LaRosa, Executive Vice President, General Counsel and Secretary
- Melissa Lozner, Senior Vice President, Chief Compliance Officer
- Marion McCourt, Executive Vice President, Commercial
- Bob McCowan, Senior Vice President, IT and Chief Information Officer
- Gonzalo Merino, PhD, Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel
- Richard O’Neal, Senior Vice President, Market Access
- Sally A. Paull, Executive Vice President, Human Resources
- Smita Pillai, Senior Vice President, Culture and DEI and Chief DEI Officer
- George Poth, Senior Vice President, Real Estate & Facilities Management
- Alessandra Ravetti, Senior Vice President, Associate General Counsel
- Kerry Reinertsen, PhD, Senior Vice President, Strategic Alliances
- David Snow, Senior Vice President, Global Head, Dupixent Franchise
- Mark Volpe, Senior Vice President, Tax
- Bola Akinlade, MD, FACP, Senior Vice President, Clinical Development, Immunology and Inflammation
- Hanne Bak, PhD, Senior Vice President, Preclinical Manufacturing and Process Development
- Aris Baras, MD, Senior Vice President, Regeneron Genetics Center®
- Ned Braunstein, MD, Executive Vice President, Regulatory Affairs and Global Patient Safety
- Gang Chen, PhD, Senior Vice President, Protein Expression Sciences
- Thomas DiCioccio, PhD, Senior Vice President, Pharmacometrics
- Benjamin Drosman, Senior Vice President, Global Development Quality & Regulatory Compliance
- Gregory Geba, MD, PhD, Senior Vice President, Global Development Scientific Council
- Philip Gregory, DPhil, Senior Vice President, Regeneron Cell Medicines
- Gary Herman, MD, Senior Vice President, Early Clinical Development and Experimental Sciences
- Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine
- Diana Hughes, MBBS, Senior Vice President, Global Patient Safety
- Bari Kowal, Senior Vice President, Development Operations and Portfolio Management
- Christos Kyratsous, PhD, Senior Vice President, Research
- Johnathan Lancaster, MD, PhD, Senior Vice President, Global Medical Affairs
- John Lin, MD, PhD, Senior Vice President, Immuno-Oncology and Head of Bispecifics
- Israel Lowy, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Oncology
- Lynn Macdonald, PhD, Senior Vice President, Research
- Lori Morton, PhD, Senior Vice President, Research
- Andrew Murphy, PhD, Executive Vice President, Research
- Muriel O'Byrne, PhD, Senior Vice President, International Regulatory Affairs & Head, European Business Office
- William Olson, PhD, Senior Vice President, Therapeutic Proteins
- Mohammed Shameem, PhD, Senior Vice President, Formulations Development
- L. Andres Sirulnik, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Hematology
- Randy Soltys, PhD, Senior Vice President, Drug Safety and Pharmacometrics
- Neil Stahl, PhD, Executive Vice President, Research and Development
- Robert Vitti, MD, Senior Vice President, Clinical Trial Excellence Strategy
- Brian Zambrowicz, PhD, Executive Vice President, Functional Genomics and Chief VelociGene® Operations
- Rajesh Ahuja, Senior Vice President, Fill/Finish and External Manufacturing
- Frederick Austin, Senior Vice President, Quality Control, Raheen
- Christine Childrose, Senior Vice President, Human Resources and HR Operations
- David Crenshaw, Senior Vice President, Associate General Counsel
- Tikiri Dissanayake, Senior Vice President, IOPS Technical Operations
- Patrice Gilooly, Senior Vice President, Quality Assurance and Operations
- Jennifer McNay, PhD, Senior Vice President, CMC Regulatory Sciences and Industrial Affairs
- Niall O’Leary, Senior Vice President and Site Head, IOPS Raheen
- Scott Oberman, Senior Vice President, Supply Chain Operations
- David Simon, Senior Vice President, IOPS Finance and Business Operations
- Daniel Van Plew, Executive Vice President and General Manager, Industrial Operations and Product Supply
- Benjamin Yocum, Senior Vice President, Manufacturing Operations
- James Wolfe, Senior Vice President, Process Sciences and Drug Product Engineering
- Bonnie L. Bassler, PhD, Director
- Michael S. Brown, MD, Director
- N. Anthony Coles, MD, Chair of the Board
- Joseph L. Goldstein, MD, Director
- Kathryn Guarini, PhD, Director
- Christine A. Poon, Lead Independent Director
- Arthur F. Ryan, Director
- Huda Y. Zoghbi, MD, Director
- Samantha Dickon, Director, Development Program Management
- Gervasio Batista, Sr. Scientist, Neuroscience
- James K. Gibson, Senior Regional Director, Immunology/Pulmonary
- Beth Brause, Director, Field Reimbursement Management
- Eric Prendergast, Director, Pricing Strategy
- Ashley Neff, Manager, Digital Communications
- Shari Loock, Associate Director, Sourcing
- Jennifer Davidson Hamilton, VP and Head of Precision Medicine
- Yi Zhang, Director, Health Economics & Outcomes Research
- Wilson Caldwell III, Director, GCO Vendor & Relationship Management
- David Stein, Director, Medical Operations
- Regeneron, Corporate
- Grant Anicete, Biotech Production Specialist I / IOPS Rensselaer
- Mary McKenna, Lead Quality Control Analyst / IOPS Raheen
- Ashley Lebby, Lead Senior Biotech Production Specialist / IOPS Rensselaer
- Varenka Rodriguez Diblasi, Principal Scientist, Bioinformatics
- Jessie Brown, Manager, Integrative Translational Genetics
- Gisu Eom, Lead Cloud DevOps Engineer
- Carmen Kenworthy, Scientist, Velocigene
- Ralph Hazlewood, Sr. Manager, Research Program Management
- Brandy Bennett, Sr. Director, R&D Strategy & Operations
Last updated: 2024-12-31
Reneo Pharmaceuticals, Inc.
REN001
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.
About | About | About | Management | Directors | Contact | Contact | Careers | Careers | About | About | About
Symbol: RPHM
Recent Price: $18.20
Industry: Biotechnology
CEO: Mr. Gregory J. Flesher
Sector: Healthcare
Employees: 8
Address: 18575 Jamboree Road, Irvine, CA 92612
Phone: 619 733 3852
Last updated: 2024-12-31
Amneal Pharmaceuticals, Inc.
Emverm, Rytary, Unithroid
Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products across various dosage forms and therapeutic areas, operating through Generics, Specialty, and Av KARE segments.
Our Story | Our Story | Our Story | Our Story | About | About | Leadership | Leadership | Leadership | Locations | About | About | About | About | About | Awards | Contact | About | About | About | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: AMRX
Recent Price: $7.83
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Chirag K. Patel
Sector: Healthcare
Employees: 7850
Address: 400 Crossing Boulevard, Bridgewater, NJ 08807
Phone: 908 947 3120
Leadership
- Chirag Patel, President and Co-Chief Executive Officer
- Chintu Patel, Co-Chief Executive Officer
- Tasos Konidaris, Executive Vice President, Chief Financial Officer
- Nikita Shah, Executive Vice President, Chief Human Resources Officer
- Jason B. Daly, Esq., Senior Vice President, Chief Legal Officer & Corporate Secretary
- Gregory Sgammato, Senior Vice President, Corporate Development
- Andrew S. Boyer, Executive Vice President, Chief Commercial Officer – Generics
- Joe Renda, Senior Vice President, Chief Commercial Officer - Specialty
- Shyamakant Giri, President, India Business & Emerging Markets
- Sanjay Kumar Jain, PhD, Chief Quality Officer
- Srinivas Kone, PhD, Senior Vice President, Chief Scientific Officer – Generics
- Richard D’Souza, PhD, Senior Vice President, Specialty R&D
- Maryll W. Toufanian, Senior Vice President, Regulatory Strategy and Government Affairs
- Pranav Mehta, Senior Vice President, Strategic Sourcing & Supply Management
- Sandeep R. Raktate, President, Operations – India & Ireland
Last updated: 2024-12-31
Altimmune, Inc.
Pemvidutide
Altimmune, Inc. focuses on developing treatments for obesity and liver diseases with lead product candidate pemvidutide, and Hep Tcell in clinical trials.
Symbol: ALT
Recent Price: $7.32
Industry: Biotechnology
CEO: Dr. Vipin K. Garg Ph.D.
Sector: Healthcare
Employees: 59
Address: 910 Clopper Road, Gaithersburg, MD 20878
Phone: 240 654 1450
Last updated: 2024-12-31
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
CervoMed Inc.
neflamapimod
Cervo Med Inc. is a clinical-stage biotechnology company focused on developing and commercializing drug treatments for neurodegenerative diseases, including neflamapimod for conditions like dementia with Lewy bodies, Alzheimer's diseases, and brain stroke recovery.
Symbol: CRVO
Recent Price: $2.39
Industry: Biotechnology
CEO: Dr. John J. Alam M.D.
Sector: Healthcare
Employees: 8
Address: 20 Park Plaza, Boston, MA 02116
Phone: 617-744-4400
Last updated: 2024-12-31
Geron Corporation
Imetelstat
Geron Corporation is a late-stage clinical biopharmaceutical company focused on developing and commercializing therapeutics for myeloid hematologic malignancies, notably through their telomerase inhibitor, imetelstat, which is in Phase 3 clinical trials.
Symbol: GERN
Recent Price: $3.40
Industry: Biotechnology
CEO: Dr. John A. Scarlett M.D.
Sector: Healthcare
Employees: 141
Address: 919 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 473 7700
Leadership
- John A. Scarlett, M.D., Chairman of the Board, President and Chief Executive Officer
- Melissa A. Kelly Behrs, Executive Vice President, Business Operations and Chief Alliance Officer
- Faye Feller, M.D., Executive Vice President, Chief Medical Officer
- Andrew J. Grethlein, Ph.D., Executive Vice President, Chief Operating Officer
- Edward Koval, Executive Vice President and Chief Business Officer
- Shannon T. Odam, Senior Vice President, Chief People Officer
- Michelle Robertson, Executive Vice President, Chief Financial Officer and Treasurer
- Scott A. Samuels, Esq., Executive Vice President, Chief Legal Officer and Secretary
- Jim Ziegler, Executive Vice President, Chief Commercial Officer
- Gaurav Aggarwal, M.D., Compensation Committee, Strategic Committee (Chair)
- Dawn C. Bir, Nominating and Corporate Governance Committee (Chair), Compensation Committee
- V. Bryan Lawlis, Ph.D., Audit Committee, Nominating and Corporate Governance Committee
- John F. McDonald, Audit Committee, Strategic Committee
- Susan M. Molineaux, Ph.D., Compensation Committee (Chair), Nominating and Corporate Governance Committee
- Elizabeth G. O’Farrell, Lead Director, Audit Committee (Chair), Strategic Committee
- Robert J. Spiegel, M.D., FACP, Compensation Committee, Nominating and Corporate Governance Committee
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
MEI Pharma, Inc.
Zandelisib
MEI Pharma, Inc. is a late-stage pharmaceutical company focused on developing and commercializing therapies for cancer treatment, including Zandelisib and Voruciclib.
About | About | About | Contact | Contact | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Site Map | Careers | Careers | Careers | About | About | About | About | About | Jobs | About
Symbol: MEIP
Recent Price: $2.45
Industry: Biotechnology
CEO: Mr. Justin J. File
Sector: Healthcare
Employees: 28
Address: 11455 El Camino Real, San Diego, CA 92130
Phone: 858 369 7100
Last updated: 2024-12-31
Mirum Pharmaceuticals, Inc.
LIVMARLI
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for rare and orphan diseases, with products like LIVMARLI and Volixibat.
Symbol: MIRM
Recent Price: $41.18
Industry: Biotechnology
CEO: Mr. Christopher Peetz
Sector: Healthcare
Employees: 294
Address: 950 Tower Lane, Foster City, CA 94404
Phone: 650 667 4085
Leadership
- Chris Peetz, Chief Executive Officer, Mirum Pharmaceuticals
- Erin Campany, Senior Vice President, Human Resources
- Eric Bjerkholt, Chief Financial Officer
- Jean-Luc Girardet, Ph.D., Senior Vice President, Technical Operations
- Vinita Kumar, Senior Vice President, Quality
- Lara Longpre, Chief Development Officer
- Joanne Quan, M.D., Chief Medical Officer
- Peter Radovich, President & Chief Operating Officer
- Paul Ross, Chief Compliance Officer
- Pamela Vig, Ph.D., Chief Scientific Officer and Head of Research
- Laura Brege, Board Member
- Patrick Heron, Managing General Partner, Frazier Healthcare Partners
- Tim Walbert, Former Chairman, President and Chief Executive Officer, Horizon Therapeutics; Sr. Advisor, Amgen
- Lon Cardon, Ph.D., FMedSci., Board Member
- William C. Fairey, Board Member
- Laurent Fischer, M.D., President & Chief Executive Officer, Adverum Biotechnologies
- Mike Grey, Chairman of the Board, Mirum Pharmaceuticals
- Saira Ramasastry, MS, MPhil, Managing Partner, Life Sciences Advisory, LLC
Last updated: 2024-12-31
Regulus Therapeutics Inc.
RG-012 and RGLS8429
Regulus Therapeutics Inc., based in San Diego, focuses on discovering and developing drugs targeting micro RNAs for treating various diseases.
Symbol: RGLS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Joseph P. Hagan M.B.A.
Sector: Healthcare
Employees: 30
Address: 4224 Campus Point Court, San Diego, CA 92121
Phone: 858 202 6300
Last updated: 2024-12-31
Rigel Pharmaceuticals, Inc.
Tavalisse
Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases.
Symbol: RIGL
Recent Price: $16.47
Industry: Biotechnology
CEO: Mr. Raul R. Rodriguez
Sector: Healthcare
Employees: 147
Address: 1180 Veterans Boulevard, South San Francisco, CA 94080
Phone: 650 624 1100
Last updated: 2024-12-31
Rezolute, Inc.
RZ358
Rezolute, Inc. is a clinical stage biopharmaceutical company focused on developing transformative therapies for metabolic diseases related to chronic glucose imbalance. Its lead product, RZ358, is aimed at treating congenital hyperinsulinism.
Symbol: RZLT
Recent Price: $4.89
Industry: Biotechnology
CEO: Mr. Nevan Charles Elam J.D.
Sector: Healthcare
Employees: 59
Address: 201 Redwood Shores Parkway, Redwood City, CA 94065
Phone: 650 206 4507
Last updated: 2024-12-31
Sorrento Therapeutics, Inc.
G-MAB antibody library, Sofusa drug delivery technology, ZTlido
Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focusing on developing therapies for various diseases, including cancer and autoimmune diseases, using innovative antibody libraries and drug delivery systems.
Symbol: SRNE
Recent Price: $0.00
Industry: Biotechnology
CEO: Dr. Henry H. Ji Ph.D.
Sector: Healthcare
Employees: 949
Address: 4955 Directors Place, San Diego, CA 92121
Phone: 858 203 4100
Last updated: 2024-12-31
Syros Pharmaceuticals, Inc.
Tamibarotene
Syros Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cancer and monogenic diseases through gene control medicines. Key products include Tamibarotene for myelodysplastic syndrome and acute myeloid leukemia, and SY-5609 for advanced solid tumors.
About | Leadership | Directors | About | Contact | Careers | Vision/Values | DEI | Careers | About | About
Symbol: SYRS
Recent Price: $0.25
Industry: Biotechnology
CEO: Mr. Conley Chee
Sector: Healthcare
Employees: 68
Address: 35 CambridgePark Drive, Cambridge, MA 02140
Phone: 617 744 1340
Leadership
- Conley Chee, President and Chief Executive Officer
- Jason Haas, Chief Financial Officer
- Gerald E. Quirk, Chief Legal & Compliance Officer; Chief Business Officer
- Lisa Roberts, VP Human Resources
- David A. Roth, M.D., Chief Medical Officer
- Kristin Stephens, Chief Development Officer
Last updated: 2024-12-31
BioCardia, Inc.
Cardi AMP Cell Therapy System
Bio Cardia, Inc. is a clinical-stage regenerative medicine company focused on developing cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Their lead candidate, the Cardi AMP Cell Therapy System, targets heart failure and myocardial ischemia, with additional developments in cell delivery and therapeutic platforms.
About | About | Leadership | Directors | Contact | Careers | Careers | About | About | About | About
Symbol: BCDA
Recent Price: $2.15
Industry: Biotechnology
CEO: Dr. Peter A. Altman Ph.D.
Sector: Healthcare
Employees: 16
Address: 320 Soquel Way, Sunnyvale, CA 94085
Phone: 650 226 0120
Leadership
- David McClung, CFO
- Edward Gillis, Sr. VP of Devices
- Debby Holmes-Higgin, MPH, VP of Clinical
- Andrew Scott Blank, Chairman
- Simon H. Stertzer, M.D., Professor of Medicine, Emeritus
- Jay M. Moyes, Director
- Bill Facteau, President and Chief Executive Officer
- Richard Krasno, Ph.D., Director
- Jim Allen, Chief Executive Officer and President
- Peter Altman, Ph.D., President and Chief Executive Officer
Last updated: 2024-12-31
Madrigal Pharmaceuticals, Inc.
resmetirom
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focusing on developing and commercializing therapeutic candidates for cardiovascular, metabolic, and liver diseases, with its lead product candidate resmetirom targeting non-alcoholic steatohepatitis.
Symbol: MDGL
Recent Price: $311.62
Industry: Biotechnology
CEO: Mr. William J. Sibold
Sector: Healthcare
Employees: 376
Address: Four Tower Bridge, West Conshohocken, PA 19428
Phone: 267 824 2827
Leadership
- BILL SIBOLD, Chief Executive Officer
- REBECCA TAUB, M.D., Director, Founder, Chief Medical Officer and President of Research & Development
- MARDI C. DIER, Chief Financial Officer
- CAROLE HUNTSMAN, Chief Commercial Officer
- CLINT WALLACE, Chief Human Resources Officer
- RONALD FILIPPO, Chief Information Officer
- STEPHEN DODGE, PHARM D, M.B.A., Senior Vice President, Global Medical Affairs
- SHANNON KELLEY, General Counsel
- MARK BARRETT, Chief Business Officer
- MARK UNDERWOOD, Senior Vice President, Business Planning & Operations
- Julian C. Baker, Chairman and Director
- Kenneth M. Bate, Director
- Raymond Cheong, M.D., Ph.D., Director
- Fred Craves, Ph.D., Director
- James M. Daly, Director
- Paul A. Friedman, M.D., Director
- Richard S. Levy, M.D., Director
- Bill Sibold, Director, Chief Executive Officer
- Rebecca Taub, M.D., Director, Founder, Chief Medical Officer and President of Research & Development
Last updated: 2024-12-31
Relmada Therapeutics, Inc.
Esmethadone (d-methadone, dextromethadone, REL-1017)
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company specializing in developing products for central nervous system (CNS) diseases. Their lead product, Esmethadone, is in Phase 3 clinical trials for treating major depressive disorder.
Symbol: RLMD
Recent Price: $0.46
Industry: Biotechnology
CEO: Dr. Sergio Traversa M.B.A., Pharm.D.
Sector: Healthcare
Employees: 20
Address: 2222 Ponce de Leon Boulevard, Coral Gables, FL 33134
Phone: 786 629 1376
Last updated: 2024-12-31